HABA Laboratories,Inc.

Tokyo Stock Exchange 4925.T

HABA Laboratories,Inc. EBIT Margin for the year ending March 31, 2024: -14.88%

HABA Laboratories,Inc. EBIT Margin is -14.88% for the year ending March 31, 2024, a -230.07% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

HABA Laboratories,Inc. EBIT Margin for the year ending March 31, 2023 was -4.51%, a -123.98% change year over year.
HABA Laboratories,Inc. EBIT Margin for the year ending March 31, 2022 was -2.01%, a -198.97% change year over year.
HABA Laboratories,Inc. EBIT Margin for the year ending March 31, 2021 was 2.03%, a -80.69% change year over year.
HABA Laboratories,Inc. EBIT Margin for the year ending March 31, 2020 was 10.53%, a -34.23% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Tokyo Stock Exchange: 4925.T

HABA Laboratories,Inc.

CEO	Ms. Noriko Koyanagi
IPO Date	June 11, 2003
Location	Japan
Headquarters	1-24-11, Kanda Sudacho
Employees	631
Sector	Consumer Discretionary
Industries Cosmetics

Description

HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products comprise shampoos, conditioners, soaps, and hair and hand treatment products. The company sells its products through mail order, shops, drug/variety stores, and internet. It has approximately 70 HABA shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was founded in 1983 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years